Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Veterinary Pathology|May 15, 2002
Prognostic significance of a new histologic grading system for canine osteosarcomaJ Kirpensteijn, M Kik, G R Rutteman, et al.
Anticancer Research|January 18, 2003
Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluationJ Kirpensteijn, E Teske, M Kik, et al.
Veterinary Journal (London, England : 1997)|June 11, 2013
Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy resultsM Zandvliet, G R Rutteman, E Teske
The Veterinary Quarterly|May 13, 1999
Evaluation of the results of a L-asparaginase-based continuous chemotherapy protocol versus a short doxorubicin-based induction chemotherapy protocol in dogs with malignant lymphomaC J Piek, G R Rutteman, E Teske
Veterinary and Comparative Oncology|November 15, 2011
A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcomaE Teske, G R Rutteman, J Kirpenstein, et al.
Veterinary and Comparative Oncology|April 12, 2012
Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphomaE Teske, A J van Lankveld, G R Rutteman
The Veterinary Record|February 7, 2003
Study of dog and cat owners' perceptions of medical treatment for cancerL B Brønden, G R Rutteman, A Flagstad, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Polyethylene glycol-L-asparaginase versus native L-asparaginase in canine non-Hodgkin's lymphomaE Teske, G R Rutteman, P van Heerde, et al.
The Veterinary Quarterly|February 27, 1998
Multi-agent chemotherapy for mast cell tumours in the dogR J Gerritsen, E Teske, J S Kraus, et al.
Anticancer Research|July 1, 1987
The occurrence of estrogen and progestin receptors and anti-estrogen binding sites (AEBS) in canine non-Hodgkin's lymphomasE Teske, C M Besselink, M A Blankenstein, et al.
Pageof 18